Detalhe da pesquisa
1.
The relationship between viral clearance rates and disease progression in early symptomatic COVID-19: a systematic review and meta-regression analysis.
J Antimicrob Chemother
; 79(5): 935-945, 2024 May 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38385479
2.
Clinical antiviral efficacy of favipiravir in early COVID-19 (PLATCOV): an open-label, randomised, controlled, adaptive platform trial.
BMC Infect Dis
; 24(1): 89, 2024 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38225598
3.
Clinical Antiviral Efficacy of Remdesivir in Coronavirus Disease 2019: An Open-Label, Randomized Controlled Adaptive Platform Trial (PLATCOV).
J Infect Dis
; 228(10): 1318-1325, 2023 11 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37470445
4.
Temporal changes in SARS-CoV-2 clearance kinetics and the optimal design of antiviral pharmacodynamic studies: an individual patient data meta-analysis of a randomised, controlled, adaptive platform study (PLATCOV).
Lancet Infect Dis
; 2024 Apr 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38677300
5.
Antiviral efficacy of molnupiravir versus ritonavir-boosted nirmatrelvir in patients with early symptomatic COVID-19 (PLATCOV): an open-label, phase 2, randomised, controlled, adaptive trial.
Lancet Infect Dis
; 24(1): 36-45, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37778363
6.
Pharmacometrics of high-dose ivermectin in early COVID-19 from an open label, randomized, controlled adaptive platform trial (PLATCOV).
Elife
; 122023 02 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-36803992
7.
Incidence and influencing factors of psychological problems among international travellers during quarantine.
J Travel Med
; 31(1)2024 Jan 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38006361